New Brunswick Scientific Retains Clear Perspective Group to Expand and Enhance Investor Awareness

New Brunswick Scientific Retains Clear Perspective Group to
Expand and Enhance Investor Awareness 


EDISON, N.J., June 10  /PRNewswire-FirstCall/ -- New Brunswick Scientific Co.,
Inc. (NASDAQ:NBSC) ("NBS") today announced that it has retained Clear
Perspective Group, LLC ("CPG") as its investor relations counsel to broaden the
company's reach and improve visibility within the investment community.

Commenting on the move, New Brunswick Scientific Chairman David Freedman
stated: "After a capital spending slowdown in 2003, the life science industry
has experienced a broad-based rebound in recent months. Improving market
conditions appear to be sustainable, boding well for the balance of this year
and beyond. Consequently, we feel it is appropriate to expand our investor
relations initiatives and increase our visibility in the financial community."

Matthew Dennis, CFA, senior managing director of Clear Perspective Group, said:
"New Brunswick Scientific fits extremely well with CPG's capabilities. We feel
the company's investment merits are very impressive yet lack notoriety among
investors. NBS' proprietary technology and products are world class and
considered the vanguard in an improving industry. Not many investors outside of
the biotech arena are aware that NBS' proprietary CelliGen Plus(R) packed- bed
perfusion bioreactor was chosen for the production of the world's first
commercially licensed gene therapy drug.

"While the company's brands are highly respected and sought-after in the life
science community, the branding of the company's stock can be noticeably
improved," he added. "CPG will expand the company's investor following by
making it easier for investors to understand and follow company developments,
concisely articulating NBS' investment merits, and introducing management to
targeted centers of influence in the capital markets, including institutional
portfolio managers, buy- and sell-side equity analysts, brokers, and financial
media.

"NBS has been producing state-of-the-art equipment for more than 50 years.
These products are critical to success in the biotechnology, pharmaceutical,
and research industries. With the company's recent complementary acquisition of
RS Biotech, it offers the essential elements found in a comprehensive industry
laboratory: biological shakers, ultra-low temperature freezers, and now carbon
dioxide incubators."

Dennis continued: "From a fundamental investment standpoint, we think NBS is
very attractive. Sales increased more than 26 percent in this year's first
quarter versus the prior-year period, gross margins have been above 40 percent
for the two most recent quarters, and the balance sheet is very sound. The debt
to equity ratio is less than 30 percent and the company creates substantial
free cash flow. Cash and equivalents have increased in each of the past four
years and the company currently has more than one dollar per share in cash."

Freedman concluded: "We selected CPG due to its strong relationship focus,
contacts in the financial community, and its experienced personnel. The
organization has constructed unique technology platforms, which we anticipate
will not only increase the awareness of our stock, but also enable us to
redirect in-house resources to other areas of the business while reducing
certain recurring costs associated with being a public company."

To be added to the company's e-mail distribution list, please click on the link
below:

  http://www.b2i.us/frame.asp?BzID=941&to=ea&Nav=1&S=0&L=1

  About New Brunswick Scientific


New Brunswick Scientific Co., Inc. (NASDAQ:NBSC) (NBS) is a leading global
provider of a comprehensive line of research equipment and scientific
instrumentation for use in the life science industry. The company's products
are used in the creation, maintenance, and control of physical and biochemical
environments required for the growth, detection, and storage of microorganisms
for medical, biological, and chemical applications, as well as environmental
research and commercial product development. NBS is a forerunner in the
research and development of pioneering equipment to meet the challenges of new
areas of advancement in the life sciences. Established in 1946, New Brunswick
Scientific is headquartered in Edison, New Jersey, with sales and distribution
facilities strategically located in the United States, Europe, and Asia. For
more information, please visit: http://www.nbsc.com/ .

About Clear Perspective Group

A full-service investor relations consulting firm, Clear Perspective Group, LLC
(CPG)(SM), benefits clients via its dedication to cultivating long- lasting
relationships while setting industry standards for effective service and cost
minimization. More than six decades of collective experience enable CPG's
managing directors to identify and clearly communicate a company's investment
merits so that the market accurately realizes the intrinsic value of its
securities. In addition to enhancing a company's image within the financial
community as it increases exposure to investors, CPG's vast assemblage of
resources and state-of-the-art technology alleviate many of the time burdens
and recurrent costs associated with public ownership. For more information,
please visit: http://www.cpg-llc.com/ .

This press release includes statements that may constitute forward-looking
statements made pursuant to the Safe Harbor provision of the Private Securities
Litigation Reform Act of 1995. This information may involve risks and
uncertainties that could cause actual results to differ materially from the
forward-looking statements. Although the Company believes that the expectations
reflected in such forward-looking statements are based on reasonable
assumptions, such statements are subject to risks and uncertainties that could
cause actual results to differ materially from those projected. Further
information concerning risk factors is described in the Company's Securities
and Exchange Commission filings. 

DATASOURCE: New Brunswick Scientific Co., Inc.



CONTACT:  Investors, Samuel Eichenbaum, Vice President, Finance and

Treasurer, New Brunswick Scientific Co., Inc., [phone], ;

or Matthew J. Dennis, CFA, NBS Investor Relations, Clear Perspective Group,

LLC, [phone],  



Web site:  http://www.nbsc.com/

http://www.cpg-llc.com/ 

Copyright